Cabotegravir (Apretude) for HIV-1 pre-exposure prophylaxis.

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Cabotegravir (Apretude) for HIV-1 pre-exposure prophylaxis.

Med Lett Drugs Ther ; 64(1644): 29-31, 2022 02 21.

Article in En | MEDLINE | ID: mdl-35171897

Subject(s)
Key words

Apretude; Cabenuva; Descovy; HIV; Truvada; adverse effects; cabotegravir; dosage; drug interactions; efficacy; emtricitabine; emtricitiabine/tenofovir; lactation; pregnancy; rilpivirine; safety; tenofovir alafenamide

Search on Google

Add to My VHL

Print

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / HIV Infections / HIV Integrase Inhibitors / Diketopiperazines Limits: Humans Language: En Journal: Med Lett Drugs Ther Year: 2022 Document type: Article Country of publication:

Search on Google

Add to My VHL

Print

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / HIV Infections / HIV Integrase Inhibitors / Diketopiperazines Limits: Humans Language: En Journal: Med Lett Drugs Ther Year: 2022 Document type: Article Country of publication: